FDA refuses application for HIV drug from CytoDyn

FDA refuses application for HIV drug from CytoDyn

More reads

• FDA refuses application for HIV drug from CytoDyn, raising more questions about its credibility. (STAT Plus)
• Pandion Therapeutics plans to raise $94 million in an IPO. (Boston Globe)
• Pharma trade group again scolds Gilead for misleading information about a rival HIV drug. (STAT Plus)